🧠 New paper in @NatMentHealth !
In Parkinson's Disease, we show that patients at risk of cognitive decline have a distinct brain fingerprint, and that patient-specific networks associate with clinical outcomes and neurochemical substrate.
Paper 👇
For patients with #FirstEpisodePsychosis unresponsive to initial antipsychotic therapy, clozapine improved symptom response rates and reduced discontinuation due to insufficient efficacy vs olanzapine or amisulpride. https://t.co/DuaJQjHUTV
Our new preprint is now available online!🎵
“Differential associations of rhythm and pitch perception with cognitive function in older adults”
https://t.co/yM4ubTkh6q
"Clozaphobia" Why is the most effective treatment for Schizophrenia shunned? Same issue with Lithium for Bipolar. Self defeating behaviour by psychiatry & health systems. Part of a wider lack of implementation of evidence based care & undermining of confidence by bad faith actors